Cost effectiveness of full coverage of the medical management of smoking cessation in France
- PMID: 23197369
- DOI: 10.1136/tobaccocontrol-2012-050520
Cost effectiveness of full coverage of the medical management of smoking cessation in France
Abstract
Objective: To estimate the incremental cost effectiveness of full coverage of the medical management of smoking cessation from the perspective of statutory health insurance (SHI) in France.
Design and population: Cost-effectiveness analysis based on a Markov state-transition decision analytic model was used to compare full SHI coverage of smoking cessation and actual coverage based on an annual €50 lump sum per insured person among current French smokers aged 15-75 years. We used a scenario approach to take into account the many different behaviours of smokers and the likely variability of SHI policy choices in terms of participation rate and number and frequency of attempts covered.
Interventions: Drug treatments for smoking cessation combined with six medical consultations including individual counselling.
Main outcomes measures: The cost effectiveness of full coverage was expressed by the incremental cost-effectiveness ratio (ICER) in 2009 euros per life-year gained (LYG) at the lifetime horizon.
Results: The cost effectiveness per LYG for smokers ranged from €1786 to €2012, with an average value of €1911. The minimum value was very close to the maximum value with a difference of only €226. The cost-effectiveness ratio was only minimally sensitive to the participation rate, the number of attempts covered and the cessation rate.
Conclusions: Compared to other health measures in primary and secondary prevention of cardiovascular disease already covered by SHI, full coverage of smoking cessation is the most cost-effective approach.
Keywords: Cessation; Economics; Public policy.
Similar articles
-
Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.PLoS One. 2016 Feb 24;11(2):e0148750. doi: 10.1371/journal.pone.0148750. eCollection 2016. PLoS One. 2016. PMID: 26909802 Free PMC article.
-
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20. Clin Ther. 2012. PMID: 22818870
-
The cost-effectiveness of call-back counselling for smoking cessation.Tob Control. 2014 Sep;23(5):437-42. doi: 10.1136/tobaccocontrol-2012-050907. Epub 2013 Jun 8. Tob Control. 2014. PMID: 23748188
-
[Efficacy and cost-effectiveness of smoking cessation courses in the statutory health insurance: a review].Gesundheitswesen. 2009 Nov;71(11):732-8. doi: 10.1055/s-0029-1214400. Epub 2009 Jun 2. Gesundheitswesen. 2009. PMID: 19492280 Review. German.
-
Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):257-64. doi: 10.1586/erp.09.28. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19527098 Review.
Cited by
-
Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health Technol Assess. 2023 Mar;27(4):1-277. doi: 10.3310/KLTG1447. Health Technol Assess. 2023. PMID: 37022933 Free PMC article.
-
Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework.Tob Control. 2023 Sep;32(5):589-598. doi: 10.1136/tobaccocontrol-2021-056825. Epub 2022 Jan 11. Tob Control. 2023. PMID: 35017262 Free PMC article.
-
Trend in Prevalence of Smoking and Motivation to Quit among Korean Adult Male Cancer Survivors over the Last 8 Years: The Korea National Health and Nutrition Examination Survey V-VII (2010-2017).Korean J Fam Med. 2021 Jul;42(4):281-287. doi: 10.4082/kjfm.19.0134. Epub 2021 Jul 20. Korean J Fam Med. 2021. PMID: 34320795 Free PMC article.
-
Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.Addiction. 2017 Jun;112(6):946-967. doi: 10.1111/add.13748. Epub 2017 Feb 15. Addiction. 2017. PMID: 28060453 Free PMC article. Review.
-
Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.PLoS One. 2016 Feb 24;11(2):e0148750. doi: 10.1371/journal.pone.0148750. eCollection 2016. PLoS One. 2016. PMID: 26909802 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical